Description of the drug
The drug DARZALEX/DARZALEX 400 MG 20 ML 1 FLK. (Daratumumab) produced by JOHNSON&JOHNSON is an effective tool in hematology. This drug is commercially known as Darzalex and contains the active substance daratumumab.
Indications for use
The drug DARZALEX/DARZALEX is intended for patients with certain hematologic diseases that require appropriate treatment and support.
Advantages
- Convenient bottle packaging
- High quality from the manufacturer JOHNSON
Effectiveness in fighting hematologic diseases
Application
The drug DARZALEX/DARZALEX should be taken according to the doctor's recommendations to achieve optimal treatment results.
Who is it suitable for
The drug is suitable for patients with hematologic diseases who require comprehensive treatment.
Search queries
This drug is also searched for as: Darzalex, Daratumumab, hematologic drug.
Characteristics
Chemical name
Даратумумаб
Commercial name
Дарзалекс
Dosage
400 мг
Number
1
Release form
Флакон